OMEROS CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
OMEROS CORP (OMER) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 714.64 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 572.11K shares, a 214.09% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 142.53K shares, a 124.06% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 240.74K shares, a 82.78% decline year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 181.70K shares, a 210.97% increase year-over-year.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 668.20K shares, a 62.55% decline from fiscal 2024.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.78M shares, a 2.89% increase from fiscal 2023.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.73M shares, a 17.29% increase from fiscal 2022.
- OMEROS CORP share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.48M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 572.11K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 714.64K shares 10-Q · filed 2026-08-12 | 955.38K shares derived: sum of 3 quarters · filed 2026-08-12 | 1.14M shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 142.53K shares 10-Q · filed 2026-05-13 | 383.27K shares derived: sum of 2 quarters · filed 2026-05-13 | 564.97K shares derived: sum of 3 quarters · filed 2026-05-13 | 747.12K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 240.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 422.43K shares derived: sum of 2 quarters · filed 2026-03-31 | 604.58K shares derived: sum of 3 quarters · filed 2026-03-31 | 668.20K shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 181.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 363.85K shares derived: sum of 2 quarters · filed 2025-11-13 | 427.46K shares 10-Q · filed 2025-11-13 | 1.83M shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 182.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 245.77K shares 10-Q · filed 2025-08-14 | 1.64M shares derived: sum of 3 quarters · filed 2025-08-14 | 1.70M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 63.62K shares 10-Q · filed 2025-05-15 | 1.46M shares derived: sum of 2 quarters · filed 2025-05-15 | 1.52M shares derived: sum of 3 quarters · filed 2025-05-15 | 1.72M shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 1.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.46M shares derived: sum of 2 quarters · filed 2025-03-31 | 1.66M shares derived: sum of 3 quarters · filed 2025-03-31 | 1.78M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 58.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 261.86K shares derived: sum of 2 quarters · filed 2024-11-13 | 386.18K shares 10-Q · filed 2024-11-13 | 680.96K shares derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | 203.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 327.75K shares 10-Q · filed 2024-08-07 | 622.53K shares derived: sum of 3 quarters · filed 2024-08-07 | 1.62M shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 124.32K shares 10-Q · filed 2024-05-15 | 419.09K shares derived: sum of 2 quarters · filed 2024-05-15 | 1.42M shares derived: sum of 3 quarters · filed 2024-05-15 | 1.66M shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | 294.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 1.30M shares derived: sum of 2 quarters · filed 2024-04-01 | 1.54M shares derived: sum of 3 quarters · filed 2024-04-01 | 1.73M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 1.24M shares derived: sum of 2 quarters · filed 2023-11-09 | 1.44M shares 10-Q · filed 2023-11-09 | 2.34M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 242.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 437.82K shares 10-Q · filed 2023-08-09 | 1.34M shares derived: sum of 3 quarters · filed 2023-08-09 | 1.55M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 195.05K shares 10-Q · filed 2023-05-09 | 1.10M shares derived: sum of 2 quarters · filed 2023-05-09 | 1.31M shares derived: sum of 3 quarters · filed 2023-05-09 | 1.48M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 904.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 1.11M shares derived: sum of 2 quarters · filed 2023-03-13 | 1.29M shares derived: sum of 3 quarters · filed 2023-03-13 | 1.48M shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 206.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 385.19K shares derived: sum of 2 quarters · filed 2022-11-09 | 574.20K shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 178.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 367.27K shares 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | 189.01K shares 10-Q · filed 2022-05-10 | |||
| 2021-09-30 | 212.64K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 348.26K shares 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | 135.62K shares 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |